Skip to main content

100 % FDI in existing pharma cos stays

The government will continue with the policy of allowing 100 per cent foreign direct investment in existing pharmaceutical firms.
In a Press Note, the Department of Industrial Policy and Promotion (DIPP), under the Ministry of Commerce and Industry, also said the Foreign Investment Promotion Board (FIPB) would decide on the contentious non-compete clause in special cases.
“The government has reviewed the position in this regard and decided that the existing policy would continue with the condition that ‘non-compete’ clause would not be allowed except in special circumstances with the approval of the FIPB,” the DIPP said in the Press Note.

The Press Note, signed by Additional Secretary Anjali Prasad, said the decision comes into force with immediate effect.
The department had earlier proposed strict norms to tighten the FDI policy for the sector amid concern that takeovers of Indian companies by multinationals have led to non-availability of affordable drugs in the country.
It had asked for a reduction in the FDI cap to 49 per cent from 100 per cent in rare or critical pharma verticals.
However, the Union Cabinet later dismissed the DIPP proposal.
In September last year, the government cleared the U.S.-based Mylan Inc’s acquisition of Bangalore-based Agila Specialties, a subsidiary of Strides Arcolab.
Earlier, another U.S. firm Abbot Laboratories acquired Piramal Health Care’s domestic business and in 2008, Japanese Daiichi Sankyo bought out Ranbaxy, the country’s largest drug maker. — IANS

Comments

Popular posts from this blog

SC asks Centre to strike a balance on Rohingya issue (.hindu)

Supreme Court orally indicates that the government should not deport Rohingya “now” as the Centre prevails over it to not record any such views in its formal order, citing “international ramifications”.

The Supreme Court on Friday came close to ordering the government not to deport the Rohingya.

It finally settled on merely observing that a balance should be struck between humanitarian concern for the community and the country's national security and economic interests.

The court was hearing a bunch of petitions, one filed by persons within the Rohingya community, against a proposed move to deport over 40,000 Rohingya refugees. A three-judge Bench, led by Chief Justice of India Dipak Misra, began by orally indicating that the government should not deport Rohingya “now”, but the government prevailed on the court to not pass any formal order, citing “international ramifications”. With this, the status quo continues even though the court gave the community liberty to approach it in …

Khar’s experimentation with Himalayan nettle brings recognition (downtoearth)

Nature never fails to surprise us. In many parts of the world, natural resources are the only source of livelihood opportunities available to people. They can be in the form of wild shrubs like Daphne papyracea and Daphne bholua (paper plant) that are used to make paper or Gossypium spp (cotton) that forms the backbone of the textile industry.

Nothing can compete with the dynamism of biological resources. Recently, Girardinia diversifolia (Himalayan nettle), a fibre-yielding plant, has become an important livelihood option for people living in the remote mountainous villages of the Hindu Kush Himalaya.

There is a community in Khar, a hamlet in Darchula district in far-western Nepal, which produces fabrics from Himalayan nettle. The fabric and the things made from it are sold in local as well as national and international markets as high-end products.

A Himalayan nettle value chain development initiative implemented by the Kailash Sacred Landscape Conservation and Development Initiati…

The Chipko movement as it stands today

The idea behind the Chipko movement originated in early 1970s from Mandal, a village in Chamoli district of Uttarakhand. Forty-three years later, Down To Earth travelled to Chamoli and Tehri Garhwal and spoke to the participants of this movement about its relevance today